These data suggested that LCN2 may negatively regulate these motility-associated signal pathways, such the MEK/ERK signaling pathway, leading to a reduction in cell migration and invasion in the NPC cells. This evidence concerns the gene LCN2 and nasopharyngeal carcinoma.